Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Vaccine|April 11, 2022
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021Chao Ma, Weiwei Sun, Tingting Tang, et al.
Human Vaccines & Immunotherapeutics|October 26, 2022
A guideline for economic evaluations of vaccines and immunization programs in ChinaHai Fang, Chen Chen, Yu Fang, et al.
Vaccine|August 28, 2022
Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort studyXiaoqi Wang, Yao Deng, Li Zhao, et al.
Emerging Infectious Diseases|January 1, 2014
Population-based surveillance for bacterial meningitis in China, September 2006-December 2009Yixing Li, Zundong Yin, Zhujun Shao, et al.
NPJ Vaccines|October 31, 2025
Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, ChinaDan Wu, Qikai Yin, Ying Zhang, et al.
Vaccine|January 20, 2015
Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007-2008Kathleen F Cavallaro, Hardeep S Sandhu, Terri B Hyde, et al.
Emerging Microbes & Infections|April 28, 2024
Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control studySiyue Jia, Zundong Yin, Hongxing Pan, et al.
The Lancet. Public Health|November 12, 2025
Seroepidemiology of hepatitis C virus infection in people aged 1-69 years in China: a national, cross-sectional studyJian Li, Lin Pang, Guowei Ding, et al.
Frontiers in Immunology|September 26, 2022
Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccinationFuzhen Wang, Baoying Huang, Huakun Lv, et al.
China CDC Weekly|February 21, 2022
Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence - China, 2021Dan Wu, Yanyang Zhang, Lin Tang, et al.
Pageof 10